Company / Gross Profit
CASTLE BIOSCIENCES INC Gross Profit History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$15.0M
FY2020
5-year range
-
FY2018-FY2020
Trend
-66.3%
vs FY2019
Sector context
#101 of 100
Health Care
What the data says
Among 100 Health Care companies, CASTLE BIOSCIENCES INC is in the bottom -1% for gross profit. Declined from $17M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2020.
Declined from $17M to $15M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom -1% in Health CareTop 101% of 100This company $15.0M Sector average $1.8B
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2020, gross profit decreased 66.3% year-over-year.
- Ranks #101 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $15.0M | -66.3% |
| FY2019 | $44.6M | +154.8% |
| FY2018 | $17.5M | - |
As of FY2020 · SEC 10-K · Updated Jul 4, 2026